News

MRC Toxicology Unit Semi-finalists - Postdoc Business Plan Competition

3 August 2021

Congratulations to Gavin D. Garland and Aristedis Sfakianos who have made it through to the semi-finals of the 2021 Chris Abell Postdoc Business Plan competition! Find more information about the competition, semi-finalists and prizes here: https://www.enterprise.cam.ac.uk/semi-finalists-announced-in-2021-postdo...

Dr Kiran Patil has been appointed as Deputy Editor for the open access journal: 'PLOS Computational Biology'

23 June 2021

This open access journal explores the " application of computational methods among disparate areas of biology" (PLOS Computaional Biology: Journal Information ). Editorial Board: PLOS Computational Biology: A Peer-Reviewed Open-Access Journal

Nature Communications featured article: Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

1 March 2021

A recently publised article from Dr. James Thaventhiran's group about the potential treatment effect of remedesvir in COVID-19 patients was chosen as a featured paper by Nature Communiactions. The scientific achivement is highlighted under the topic of "Microbiology and Infectious diseases" in the journal's January issue .

Cryo-EM structural analysis reveals Caspase-8 catalytic domain architecture for co-ordinated control of cell fate

17 February 2021

Marion MacFarlane, MRC Investigator and Deputy Director at the MRC Toxicology Unit is the senior author of a new study published in Nature Communications which reveals how ‘Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate’. “The core FADD...

Cooperation is key to success in microbial communities

12 January 2021

Dr Kiran Patil, Director of Research at the MRC Toxicology Unit is the senior author of a new study which shows how cooperation among bacterial species allows them to thrive as a community. This research is from the MRC Toxicology Unit at the University of Cambridge and the European Molecular Biology Laboratory (EMBL). "If...

Remdesivir likely to be highly effective antiviral against SARS-CoV-2

14 December 2020

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature Communications, the researchers describe giving the drug to a patient with COVID-19 and a rare immune disorder, and observing a dramatic improvement in his symptoms and...

Dr Tim Allen awarded the 2020 LUSH Science Prize

12 November 2020

In silico models to predict human molecular initiating events: Congratulations to Dr Tim Allen who has been awarded the 2020 LUSH Science Prize for his research in collaboration with Unilever. More info. https://lushprize.org/2020-prize/2020-prize-winners/ 20201029_142027.jpg dsc06230.jpg

Researchers test a drug that may allow more cancer patients to benefit from immunotherapy in the future

3 November 2020

Immunotherapy can be a lifesaver for cancer patients, but some patients' tumours don't respond well to this treatment. However, researchers are encouraged by a recent clinical trial that suggests that it may be possible to expand immunotherapy to help more people in the future. Immunotherapy works by marshalling the body's...

Medicines Safety (Toxicology) Research Fellowship Available in 2020. Cambridge UK

10 August 2020

The Cambridge Alliance on Medicines Safety Fixed-term: Funding for this post is available for 3 years The Cambridge Alliance on Medicines Safety (CAMS; https://www.ats.cam.ac.uk/what-we-do/cambridge-alliance-medicines-safety ) is delighted to be able to offer a Junior Research Fellowship in epigenetic drug safety and...

Congratulations to Kathryn Lilley, Director of the Cambridge Centre for Proteomics, who has been awarded an EMBO membership.

8 July 2020

Kathryn works closely with members of the Unit and will be based in the Gleeson building from November. Professor Kathryn Lilley has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research. Speaking about her election, Kathryn said: “ I feel...

MRC Toxicology Unit Semi-finalists - Postdoc Business Plan Competition

Dr Kiran Patil has been appointed as Deputy Editor for the open access journal: 'PLOS Computational Biology'

Nature Communications featured article: Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

Cryo-EM structural analysis reveals Caspase-8 catalytic domain architecture for co-ordinated control of cell fate

Cooperation is key to success in microbial communities

Remdesivir likely to be highly effective antiviral against SARS-CoV-2

Dr Tim Allen awarded the 2020 LUSH Science Prize

Researchers test a drug that may allow more cancer patients to benefit from immunotherapy in the future

Medicines Safety (Toxicology) Research Fellowship Available in 2020. Cambridge UK

Congratulations to Kathryn Lilley, Director of the Cambridge Centre for Proteomics, who has been awarded an EMBO membership.

Contact Us

Connect with us

Study at Cambridge

About the University

Research at Cambridge